NEWS RELEASES
Search all of our news releases here.
AGT CSO, David Pauza, to Present HIV cure data At The Cell & Gene Meeting on the Mesa
ROCKVILLE, MD., September. 26, 2017 (GLOBE NEWSWIRE) — American Gene Technologies International Inc. (AGT), a gene technology company focusing on a lentiviral delivery platform, today announced that Chief Science Officer C. David Pauza, Ph.D., will present at the upcoming Cell & Gene Meeting on the Mesa…
Read MoreAGT Builds Montgomery County Gene & Cell Therapy Momentum
Fast Growing Maryland Biotech Company Moves to a 24,000 Sq. Ft. Location and Will Host Ribbon Cutting Ceremony on October 23, 2017. September 25, 2017. Montgomery County, MD: American Gene Technologies (AGT), a private Maryland biotechnology company developing cures and treatments for Infectious diseases, cancers and monogenic disorders,…
Read MoreAmerican Gene Technologies Inc. Appoints Julia R. Brown to its Board of Directors
ROCKVILLE, Md., Sept. 11, 2017 (GLOBE NEWSWIRE) – American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company with a broad and robust lentiviral drug-development platform, today announced the appointment of Julia R. Brown to its board of directors. Jeffrey A. Galvin…
Read MoreAGT’s CEO to Present at the 2017 BIO International Convention
ROCKVILLE, MD, June 07, 2017 American Gene Technologies International Inc. (AGT), a genetic medicine company with a broad, robust lentiviral delivery platform, announced today that its CEO, Jeff Galvin, is presenting at the upcoming BIO International Convention. The Convention is being held on June 19-22,…
Read MoreAGT CEO, Jeff Galvin, to Present at HIMSS Precision Medicine Summit
ROCKVILLE, MD, May 31, 2017 – American Gene Technologies International Inc. (AGT), a gene technology company with a broad and robust lentiviral delivery platform, today announced that Jeff Galvin, CEO, will present at the upcoming Health Information Management System Society (HIMSS) Precision Medicine Summit, being…
Read MoreAmerican Gene Technologies Announces Appointment of C. Neil Lyons as Chief Financial Officer
Rockville, Maryland, April 12, 2017 American Gene Technologies International Inc. (AGT), a genetic drug development company, announced the appointment of C. Neil Lyons as Executive Vice President and Chief Financial Officer. Mr. Lyons joins AGT with over a decade of experience leading finance for clinical-stage,…
Read MoreAmerican Gene Technologies Announces Collaboration with GeoVax for HIV cure
Clinical Trial Expected to Commence in 2017 Rockville, MD, March 14, 2017 American Gene Technologies International Inc. (“AGT“) – announced today its collaboration with GeoVax Labs, Inc. (OTCQB: GOVX) for the conduct of a Phase 1 clinical trial investigating AGT’s viral vector technology as a functional…
Read MoreAGT’s CEO to Present at the 19th BIO CEO & Investor Conference
Rockville, MD American Gene Technologies (AGT), a gene technology company with a broad, robust lentiviral delivery platform, announced today that the CEO, Jeff Galvin is presenting at the upcoming BIO CEO & Investor conference. The Conference is being held on February 13 -14, at the…
Read MoreAGT’s CEO to Present at NobleCon13
View: 1.27.16 Press Release – NobleCon13 View: Noble Conference – Investor Presentation View: Webcast
Read MoreInternationally Recognized Molecular Researcher Joins American Gene Technologies as Collaborator
ROCKVILLE, MARYLAND (October 4, 2016) – American Gene Technologies International, Inc. (AGT) today announced the appointment of Dr. John J. Rossi, PhD as a collaborator on gene therapy research. Dr. Rossi is a leader in the field of molecular biology and a pioneer in the…
Read MoreSubscribe to News Releases and News Updates
Subscribe to our news release and published article updates to be notified when we release new content!